ID

17761

Description

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Early Withdrawal.

Keywords

  1. 10/3/16 10/3/16 -
  2. 12/9/16 12/9/16 -
Uploaded on

October 3, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Early Withdrawal

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Early Withdrawal

General Information
Description

General Information

Protocol Identifier: AVA100193
Description

Protocol Identifier

Data type

boolean

Subject Identifier
Description

Subject Identifier

Data type

integer

Visit Date
Description

Visit Date

Data type

date

Visit Description: Early Withdrawal
Description

Visit Description

Data type

boolean

Instructions
Description

Instructions

Instructions completed
Description

Instructions completed

Data type

boolean

Vital signs
Description

Vital signs

Weight
Description

Weight

Data type

float

Measurement units
  • kg
kg
Blood pressure: systolic
Description

Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.

Data type

integer

Blood pressure: diastolic
Description

Blood pressure

Data type

integer

Measurement units
  • mmHg
mmHg
Heart rate
Description

Heart rate

Data type

integer

Measurement units
  • bpm
bpm
Central Laboratory (Non Fasting Samples)
Description

Central Laboratory (Non Fasting Samples)

Date samples taken
Description

Date samples taken

Data type

date

Pregnancy test: pregnant
Description

If subject is female and of childbearing potential a serum pregnancy test must be performed.

Data type

boolean

Concomitant Medications
Description

Concomitant Medications

Concomitant Medications
Description

Concomitant Medications

Data type

text

Adverse Events
Description

Adverse Events

Non-Serious Adverse Events/Serious Adverse Events
Description

Non-Serious Adverse Events/Serious Adverse Events

Data type

text

Physical Examination
Description

Physical Examination

Results from Physical Examination
Description

Results from Physical Examination

Data type

text

Pedal Oedema
Description

Pedal Oedema

Depth of Indentation
Description

Depth of Indentation

Data type

text

Indicate which ankle was assessed at this visit
Description

Ankle

Data type

text

Further Instructions
Description

Further Instructions

Instructions followed and next visit scheduled?
Description

Instructions followed and next visit scheduled?

Data type

boolean

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Early Withdrawal

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Visit Date
Item
Visit Date
date
Visit Description
Item
Visit Description: Early Withdrawal
boolean
Item Group
Instructions
Instructions completed
Item
Instructions completed
boolean
Item Group
Vital signs
Weight
Item
Weight
float
Blood pressure
Item
Blood pressure: systolic
integer
Blood pressure
Item
Blood pressure: diastolic
integer
Heart rate
Item
Heart rate
integer
Item Group
Central Laboratory (Non Fasting Samples)
Date samples taken
Item
Date samples taken
date
Pregnancy test
Item
Pregnancy test: pregnant
boolean
Item Group
Concomitant Medications
Concomitant Medications
Item
Concomitant Medications
text
Item Group
Adverse Events
Non-Serious Adverse Events/Serious Adverse Events
Item
Non-Serious Adverse Events/Serious Adverse Events
text
Item Group
Physical Examination
Results from Physical Examination
Item
Results from Physical Examination
text
Item Group
Pedal Oedema
Item
Depth of Indentation
text
Code List
Depth of Indentation
CL Item
< 1 mm (1)
CL Item
1-2 mm (2)
CL Item
3-5 mm (3)
CL Item
6-10 mm (4)
CL Item
> 10 mm (5)
Item
Indicate which ankle was assessed at this visit
text
Code List
Indicate which ankle was assessed at this visit
CL Item
Right Ankle (1)
CL Item
Left Ankle (2)
Item Group
Further Instructions
Instructions followed and next visit scheduled?
Item
Instructions followed and next visit scheduled?
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial